The Centers for Medicare & Medicaid Services Office of Minority Health (CMS OMH) released a new interactive map to increase understanding of geographic disparities in chronic disease among Medicare beneficiaries.
St. Jude Medical Inc. announced CE Mark approval and launch of three new Quartet left ventricular (LV) leads, offering additional electrode spacing options and one new lead shape.
NeoChord Inc. announced that David H. Adams, M.D., and Michael A. Borger, M.D., Ph.D., will serve as national co-principal investigators of the company’s U.S. pivotal trial scheduled to commence later this year.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
A person’s healthcare records contain a wealth of sensitive information. This does not involve just their medical ...
AliveCor, Inc., the leader in FDA-cleared electrocardiogram (ECG) technology for mobile devices, announced today the ...
Merge Healthcare, an IBM company, offers award-winning cardiology and hemodynamics solutions that provide a complete ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Civco Medical Solutions announced that it has acquired PCI Medical, a market leader in high-level disinfection products for ultrasound transducers. The acquisition equips Civco with a portfolio of hardware and consumables for cost-effective infection control compliance in the ultrasound transducer reprocessing market.
Conventional ultrasound systems too often yield non-diagnostic exams. Recognizing this, GE Healthcare has developed an ...
NuCryo Vascular LLC announced the launch of the Next Generation Cryoplasty Inflation device. The device received U.S. Food and Drug Administration (FDA) 510(k) clearance in late 2015 and works in conjunction with the PolarCath Balloon Dilatation System.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
V-Wave Ltd, maker of an investigational interatrial shunt device for patients with advanced heart failure (HF), announced the results of its first human implants were published in The Lancet.
Routine mammography, widely recommended for breast cancer screening, may also be a useful tool to identify women at risk for heart disease, according to a study scheduled for presentation at the American College of Cardiology's (ACC) 65th Annual Scientific Session.
Millions of percutaneous coronary interventions (PCIs) are performed each year around the world to treat obstructive ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Acute pulmonary embolism (PE) can pose a major treatment quandary for clinicians. While massive (high-risk) PE is ...
Emory St. Joseph’s Hospital in Atlanta took control of more than $2.5 million in cardiovascular inventory by automating ...
Duke University researchers have taken a major step towards realizing a new form of magnetic resonance imaging (MRI) that could record biochemical reactions in the body as they happen.